Search results for "From Annals of Internal Medicine"
In the Clinic, Ideas and Opinions address diabetes
A recent In the Clinic reviewed hyperglycemia in hospitalized patients, and an opinion article discussed misuse of race in interpretation of HbA1c levels.
https://diabetes.acponline.org/archives/2024/12/13/8.htm
13 Dec 2024
Medicare coverage of semaglutide would be costly
Covering semaglutide for patients who are overweight and have cardiovascular disease could cost Medicare an additional $34 to $145 billion annually, researchers estimated.
https://diabetes.acponline.org/archives/2024/09/13/7.htm
13 Sep 2024
Little difference in dementia risk with SGLT-2s vs. dulaglutide
Older patients with type 2 diabetes starting sodium-glucose cotransporter-2 (SGLT-2) inhibitors had an estimated difference of less than a percentage point in five-year risk of clinical onset of dementia compared with those starting the glucagon-like peptide-1 receptor agonist dulaglutide, a South Korean study found.
https://diabetes.acponline.org/archives/2024/09/13/6.htm
13 Sep 2024
Use of GLP-1 receptor agonists rose steeply in past decade, study finds
A million U.S. patients, mostly women, started taking glucagon-like peptide-1 (GLP-1) receptor agonists between 2011 and 2023, according to an analysis of medical records across the country.
https://diabetes.acponline.org/archives/2024/08/09/6.htm
9 Aug 2024
Latest Beyond the Guidelines, In the Clinic target diabetes
An endocrinologist and a nephrologist discuss appropriate care for type 2 diabetes and chronic kidney disease, and the evidence supporting type 2 diabetes prevention and treatment are reviewed.
https://diabetes.acponline.org/archives/2024/06/14/6.htm
14 Jun 2024
SGLT-2 inhibitors associated with improved outcomes in stage 5 CKD patients
Patients with type 2 diabetes and stage 5 chronic kidney disease (CKD) had lower risk of progressing to dialysis or having a cardiovascular event if they took sodium-glucose cotransporter-2 (SGLT-2) inhibitors, a study found.
https://diabetes.acponline.org/archives/2024/05/10/6.htm
10 May 2024
State caps on insulin costs for commercially insured didn't increase insulin use
Limits on out-of-pocket costs did lower patients' insulin expenses, but the effect was mostly limited to those with health savings accounts, a pre-post comparison among U.S. states found.
https://diabetes.acponline.org/archives/2024/04/12/6.htm
12 Apr 2024
Annals On Call: Type 1 diabetes
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode discussed the age at which U.S. adults with type 1 diabetes are being diagnosed.
https://diabetes.acponline.org/archives/2023/12/08/8.htm
8 Dec 2023
Diabetes more common in low-income middle-aged people, rising among higher-income group
Between 1999 and 2020, rates of diabetes and obesity held steady in lower-income middle-aged adults in the U.S., while these risk factors rose among the higher-income middle-aged, from 7.8% to 14.9% and 33.0% to 44.0%, respectively.
https://diabetes.acponline.org/archives/2023/12/08/7.htm
8 Dec 2023
Finerenone works by quickly lowering albuminuria, analysis finds
Reductions in the urine albumin-to-creatinine ratio within four months were responsible for 84% of the treatment effect of finerenone on kidney outcomes and 37% of that on cardiovascular outcomes, according to an industry-funded four-year analysis of trials in patients with chronic kidney disease and type 2 diabetes.
https://diabetes.acponline.org/archives/2023/12/08/6.htm
8 Dec 2023
Weekly insulin icodec superior to daily insulin analogues in latest manufacturer trial
Patients with type 2 diabetes who used weekly insulin icodec and a dosing app had greater reductions in HbA1c levels than similar patients randomized to start a daily insulin analogue with a traditional dosing strategy.
https://diabetes.acponline.org/archives/2023/10/13/6.htm
13 Oct 2023
Insulin costs, diabetes and testosterone
An Ideas and Opinions piece explained some of the factors behind insulin prices, and a meta-analysis looked at testosterone levels in men with diabetes.
https://diabetes.acponline.org/archives/2023/09/08/6.htm
8 Sep 2023
Crowdfunding campaigns often focus on overall cost of diabetes, rarely mention insulin
A quarter of fundraisers for patients with diabetes reported that the patient had insurance, and many mentioned noncovered costs such as lost wages, healthy food, and diabetic alert dogs.
https://diabetes.acponline.org/archives/2023/07/14/6.htm
14 Jul 2023
ACP Journal Club: SGLT-2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes
The results of this meta-analysis of sodium-glucose cotransporter-2 (SGLT-2) inhibitors highlight the opportunity for internists, nephrologists, endocrinologists, and cardiologists to collaborate to expand use of the drug class, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2023/03/10/7.htm
10 Mar 2023
Annals On Call: First-line drug therapy for type 2 diabetes
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode covered a study of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists as first-line therapy.
https://diabetes.acponline.org/archives/2023/03/10/6.htm
10 Mar 2023
Low-carb diet improved diabetes control, but effects didn't last
Patients with type 2 diabetes randomized to a low-carb, high-fat diet for six months showed more improvement in HbA1c level than those assigned to a low-fat, high-carb diet, a Danish trial found.
https://diabetes.acponline.org/archives/2023/01/13/6.htm
13 Jan 2023
California's insulin plan, clinical decision support in lower-income countries
Recent articles from Annals of Internal Medicine discussed California's plan to produce insulin and a diabetes clinical decision support system that may be helpful in primary care in low- to middle-income countries.
https://diabetes.acponline.org/archives/2022/12/09/8.htm
9 Dec 2022
More than 15% of U.S. insulin users had to ration in the past year, study finds
Rationing was more common among younger patients, Black patients, and uninsured patients, according to an analysis of the 2021 National Health Interview Survey.
https://diabetes.acponline.org/archives/2022/11/11/7.htm
11 Nov 2022
Recent articles address federal diabetes programs, type 1 diabetes care
The National Clinical Care Commission made 39 recommendations for improving federal diabetes programs, and the latest In the Clinic article offered advice on diagnosing and treating type 1 diabetes.
https://diabetes.acponline.org/archives/2022/03/11/6.htm
11 Mar 2022
Bariatric surgeries reduced hepatic steatosis in type 2 diabetes at one year
Patients who were randomized to either sleeve gastrectomy or Roux-en-Y gastric bypass showed similar improvements in hepatic steatosis and fibrosis, a randomized trial in Norway found.
https://diabetes.acponline.org/archives/2021/12/10/6.htm
10 Dec 2021